VALIDACIÓN EXTERNA DE LA UTILIDAD DE LOS PARÁMETROS DE DEFORMACIÓN MIOCÁRDICA EN EL RECHAZO AGUDO DEL INJERTO.

Article. 10.1007/s40292-021-00476-4. 2021

Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1097/TP.0000000000004273. 2022

Alterations in the Nucleocytoplasmic Transport in Heart Transplant Rejection.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.09.003. 2021

Analysis of complications in patients with ECMO as a bridge to transplantation since the beginning of the technique (2007-2023)

Guerrero Cervera, Borja; (...); Almenar Bonet, Luis

Meeting Abstract. 2024

Analysis of Heart Transplant Survival According to Difference in Age Between Donor and Recipient.

Article. 10.1016/j.transproceed.2022.10.014. 2022

Analysis of heart transplantation survival according to difference in age between donor and recipient

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Analysis of hospital mortality and primary graft dysfunction in urgent heart transplantation according to the type and duration of circulatory/ventricular assistance

Meeting Abstract. 2017

Analysis of the implantation of heart failure with reduced ejection fraction treatment in clinical practice and its impact on achieving target doses

Esteban Fernandez, A. Alberto; (...); Fernandez, V. Alonso

Meeting Abstract. 2023

Analysis of the Intrahospital and Long-Term Survival of Heart Transplant Patients With a Short-Term Mechanical Assistance Device.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.1016/j.transproceed.2021.06.030. 2021

Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction.

Article. 10.1186/s12872-024-03728-y. 2024

beta 2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation

Rodriguez-Serrano, M; (...); D'Ocon, P

Article. 10.3389/fphar.2019.00093. 2019

Bridge to cardiac transplantation with temporary mechanical circulatory support: trends and outcomes in Spain (2010-2020)

Barge Caballero, E. Eduardo; (...); Crespo-Leiro, M.

Meeting Abstract. 2022

CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Correction. 10.1016/j.rec.2023.03.018. 2023

CA125: a new biomarker in patients with Fontan circulation.

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Article. 10.1016/j.rec.2022.05.029. 2022

Can the number of Comorbidities predict readmissions for Heart Failure patients?

Ferre, MFM; (...); Almenar, L

Meeting Abstract. 2018

Can we start quadruple therapy in new-diagnosed heart failure patients in real life? Insights into the basal characteristics of TIDY-HF register

Esteban Fernandez, A.; (...); Torres Lego, J.

Meeting Abstract. 2022

Carbohydrate antigen 125 and glutamic oxaloacetic transaminase as congestion markers in acute heart failure. Is there clinical association between them?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Cardiac Allograft Rejection Induces Changes in Nucleocytoplasmic Transport: RANGAP1 as a Potential Non-Invasive Biomarker.

Lozano-Edo, Silvia; (...); Martinez-Dolz, Luis

Article. 10.3390/jpm12060913. 2022

Cardiac S1P/Ceramide imbalance in human heart failure: implication of gene dysregulation

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021

Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy.

Alania-Torres, Edgardo; (...); Valle-Munoz, Alfonso

Case Reports. 10.3389/fcvm.2021.759119. 2021

CCSER2 and RAC3 serum expression levels detect cardiac allograft rejection

Rodriguez, J. M.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Circulating biomarkers for the detection of the pre-capillary component in patients with pulmonary hypertension due to left heart diseases

Ferrer, JLM; (...); Bonet, LA

Meeting Abstract. 2017

Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection.

Pérez-Carrillo L; (...); Roselló-Lletí E

Letter. 10.1186/s40364-024-00590-0. 2024

Clinical features and outcomes of adult patients with single ventricle physiology not undergoing Fontan repair

Gordon, B; (...); Rueda, J

Meeting Abstract. 2020

Clinical phenotypes according to diuretic combination in acute heart failure.

Article. 10.1016/j.hjc.2023.03.009. 2023

Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial

Esteban-Fernandez, Alberto; (...); VERISEC Registry Researchers

Article. 10.3389/fcvm.2024.1504427. 2025

Clinical profile of heart failure patients starting vericiguat in clinical practice

Esteban Fernandez, A. Alberto; (...); Diez Villanueva, P.

Meeting Abstract. 2024

Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.

Article. 10.3389/fcvm.2024.1381514. 2024

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry.

Alonso Salinas, Gonzalo Luis; (...); Diez-Villanueva, Pablo

Article. 10.1002/ehf2.15260. 2025

Clinical Utility of the IMPACT Score for Mortality Prediction after Heart Transplantation: External Validation Study

Bautista, CDO; (...); Jimenez, JFD

Meeting Abstract. 10.1016/j.healun.2019.01.517. 2019

Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients.

Pérez-Carrillo L; (...); Roselló-Lletí E

Article. 10.1097/TP.0000000000004622. 2023

Combining serum miR-144-3p and miR-652-3p as potential biomarkers for the early diagnosis and stratification of acute cellular rejection in heart transplantation patients

Perez-Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022

COMPARATIVE ANALYSIS OF SURVIVAL OF PATIENTS WITH CONGENITAL HEART DISEASE TRANSPLANTED FROM HEART OR HEART-LUNG

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Article. 10.3390/biomedicines12092109. 2024

Complications After Heart Transplantation According to the Type of Pretransplant Circulatory/Ventricular Support.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.08.040. 2021

Comprehensive survival analysis in acute heart failure: profiling patients through clinical examination at admission

Raquel Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2024

Consensus on the management of hyperkalemia in patients with heart failure: recommendations from the SEC-SEMI

Bonet, L. Almenar, Gonzalez-Franco, A.

Article. 10.1016/j.rce.2020.11.009. 2022

Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI.

Almenar Bonet, L, Gonzalez-Franco, A

Article. 10.1016/j.rceng.2020.11.012. 2021

Correlates of musculoskeletal pain and kinesiophobia in older adults with heart failure: A structural equation model.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1016/j.gerinurse.2023.07.003. 2023

Correlation of various molecules involved in cellular traffic with the severity of heart failure in patients undergoing cardiac transplantation

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018

COVID-19 AND CARDIAC TRANSPLANTATION. EXPERIENCE IN A TERTIARY HOSPITAL

Trenado, VD; (...); Almenar-Bonet, L

Meeting Abstract. 2021

COVID-19 and Heart Transplantation. Initial Experience in a Tertiary Hospital.

Article. 10.1016/j.transproceed.2021.07.054. 2021

COVID-19 infection in heart transplants in pre- and post-vaccination periods

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.005. 2022

Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.

Article. 10.1080/00015385.2020.1871264. 2021

Current Situation and Prognostic Evolution of Combined Heart-lung Transplantation in a European Union Country

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Article. 2022

CURRENT STATUS AND DEVELOPMENT OF CARDIOPULMONARY TRANSPLANTATION IN SPAIN

Meeting Abstract. 2021

Changes in Adrenoceptor and GRK Expression in Patients With Chronic Pulmonary Regurgitation.

Rodríguez-Serrano M; (...); Martínez-Dolz L

Article. 10.1016/j.rec.2018.05.030. 2019

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design

Minana, G; (...); Myocardial-IRON Investigators

Article. 10.1002/clc.22956. 2018

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study

Escribano-Subias, P; (...); Barbera, JA

Article. 10.1186/s12890-020-01197-5. 2020

Changes in the Treatment of Decompensated Advanced Heart Failure During Hospitalization and at Discharge.

Article. 10.1016/j.transproceed.2022.10.002. 2022

Changes over the years in the indication for heart-lung transplantation in Spain

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

De una asistencia biventricular mínimamente invasiva al implante de Heartware.

Pérez-Guillén M; (...); Torregrosa-Puerta S

Article. 10.24875/ACM.21000073. 2022

Depression mediates physical activity readiness and physical activity in patients with heart failure

Deka, Pallav; (...); Marques-Sule, Elena

Article. 10.1002/ehf2.13609. 2021

Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease

Braza-Boils A; (...); Zorio E

Article. 10.1111/liv.13097. 2016

Destination Therapy Strategies of Advanced Heart Failure in Elderly Non-Heart Transplant Candidates: A Propensity Matching Analysis from the LEVO-D and REGALAD Registries

Dobarro, David; (...); Gonzalez-Costello, Jose

Article. 10.3390/life14121570. 2024

Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.1016/j.healun.2021.10.004. 2022

Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing

Nunn LM; (...); Lambiase PD

Article. 10.1093/europace/euv285. 2016

Does the age of the recipient influence the survival of the heart transplant?

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Donor-derived cell-free DNA as a new biomarker for cardiac allograft rejection: A prospective study (FreeDNA-CAR).

Jimenez-Blanco, Marta; (...); Segovia-Cubero, Javier

Article. 10.1016/j.healun.2024.11.009. 2024

Donor-Derived Cell-Free DNA as a Potential Biomarker for Acute Cellular Rejection Surveillance (FreeDNA-CAR Study)

Bravo, M. Jimenez -Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023

Donor-Derived Cell-Free DNA Correlates Well with NT-ProBNP in Heart Transplant Recipients Undergoing Routine Endomyocardial Biopsies During First Year Post-Heart Transplant

Bravo, M. Jimenez-Blanco; (...); Segovia-Cubero, J.

Meeting Abstract. 2023

Donor-Transmitted Coronary Artery Disease in Heart Transplantation: Prevalence and Characteristics in the Real World. Results from the Multicentric Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2022

Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry.

Gomez-Bueno, Manuel; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2022.07.011. 2022

Effects of COVID-19 Lockdown on Heart Failure Patients: A Quasi-Experimental Study.

Sánchez-González JL; (...); Marques-Sule E

Article. 10.3390/jcm12227090. 2023

Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.

Gonzalez-Vilchez, F; (...); de Prada, JAV

Article. 10.1016/j.rec.2017.03.014. 2018

EPIDEMIOLOGICAL STUDY OF TRICUSPID REGURGITATION AFTER CARDIAC TRANSPLANTATION. DOES IT INFLUENCE SURVIVAL?

Meeting Abstract. 2021

Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?

Article. 10.3389/ti.2022.10197. 2022

Essential ECG clues in patients with congenital heart disease and arrhythmias

Cano, O; (...); Martinez-Dolz, L

Article. 10.1016/j.jelectrocard.2016.08.005. 2017

Evaluation of a near-zero fluoroscopic approach for catheter ablation in patients with congenital heart disease

Cano, O; (...); Mart?nez-Dolz, L

Article. 10.1007/s10840-018-0467-3. 2019

Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study

Sarmiento, E; (...); Carbone, J

Article. 10.1016/j.healun.2016.10.004. 2017

Evolutionary description of heart transplantation and heart-lung transplantation in congenital heart disease

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Evolutionary Description of Heart Transplantation and Heart-Lung Transplantation in Congenital Heart Disease.

Donoso Trenado, Victor; (...); Almenar-Bonet, Luis

Article. 10.1016/j.transproceed.2022.10.006. 2022

Evolving Indications for Heart-Lung Transplant in Spain.

Article. 10.1016/j.transproceed.2022.10.003. 2022

Experience with COVID-19 heart transplant patients in a tertiary hospital

Donoso, V.; (...); Almenar Bonet, L.

Article. 2021

Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life

Esteban-Fernandez, Alberto; (...); Lopez-Vilella, Raquel

Article. 10.1002/ehf2.13976. 2022

Facilitators and barriers to perform physical activity in patients post-heart transplantation: a qualitative study.

Klompstra L; (...); Marques-Sule E

Article. 10.1093/eurjcn/zvae144. 2024

Gender differences in heart transplantation: Twenty-five year trends in the nationwide Spanish heart transplant registry.

García-Cosío MD; (...); Delgado-Jiménez JF

Article. 10.1111/ctr.14096. 2020

Genotype FBN1/Phenotype relationship in a cohort of patients with Marfan syndrome.

Hernándiz A; (...); Sepúlveda P

Article. 10.1111/cge.13879. 2020

Golgi ribbon integrity in human patients with chronic heart failure

Gimenez Escamilla, I.; (...); Tarazon, E.

Meeting Abstract. 2021

Heart failure patients with reduced left ventricular ejection fraction, who reached 100% target dose of beta-blockers in randomized and observational studies

Artola, MJMJO; (...); Esteban, A

Meeting Abstract. 2018

Heart transplantation and heart-lung transplantation in congenital heart disease. experience in a tertiary referral hospital

Donoso, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

How much does right ventricular dysfunction influence the elevation of NT-proBNP in patients with acute heart failure?

Meeting Abstract. 2018

Hyperkalemia in heart failure patients: current challenges and future prospects

Review. 10.2147/RRCC.S75680. 2016

Hypertonic saline solution with furosemide for the treatment of congestive symptoms of acute heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Idarucizumab in High-risk Thoracic Surgery

Article. 2018

Identification of sarcomere serum biomarkers for non-invasive diagnosis of cardiac rejection

Perez Carrillo, L.; (...); Esther Rosello-Lleti, E.

Meeting Abstract. 2021

Impact of Circulatory Assistance in the Early Evolution After Heart Transplantation. Unicentric Experience.

Martinez-Lauwers, Ana; (...); Martinez-Dolz, Luis

Article. 10.1016/j.transproceed.2021.08.041. 2021

Impact of circulatory assistance in the early evolution after heart transplantation: unicentric experience.

Martinez-Lauwers, A.; (...); Martinez-Dolz, L.

Meeting Abstract. 2020

Impact of comorbidities in outpatients with chronic heart failure

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.

Article. 10.1016/j.recesp.2020.02.018. 2020

Impact of intravenous ferric carboxymaltose on heart failure with preserved and reduced ejection fraction.

Article. 10.1002/ehf2.13753. 2022

Impact of left ventricular unloading on postheart transplantation outcomes in patients bridged with VA-ECMO.

Enríquez-Vázquez D; (...); Crespo-Leiro MG

Article. 10.1016/j.rec.2024.09.005. 2024

Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation

Enriquez Vazquez, D.; (...); Crespo-Leiro, M.

Meeting Abstract. 2024

Impact on Survival of Heart and Heart-Lung Transplantation in Patients With Cyanotic and Noncyanotic Congenital Heart Diseases.

Donoso-Trenado, Victor; (...); Almenar-bonet, Luis

Article. 10.1016/j.transproceed.2024.12.005. 2024

Implication of Sphingolipid Metabolism Gene Dysregulation and Cardiac Sphingosine-1-Phosphate Accumulation in Heart Failure.

Perez-Carrillo, Lorena; (...); Tarazon, Estefania

Article. 10.3390/biomedicines10010135. 2022

Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure

Perez Carrillo, L.; (...); Tarazon, E.

Meeting Abstract. 2021

Implications of Molecular Markers in Brain-Dead Donors in Primary Graft Dysfunction and Rejection After Heart Transplantation: The Potential Role of Preconditioning

Herrador-Galindo, L.; (...); Moreno-Gonzalez, G.

Meeting Abstract. 10.1016/j.healun.2024.02.526. 2024

Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial.

Santas E; (...); Núñez J

Article. 10.1002/ehf2.14630. 2023

Incidence and factors related to vasoplegia in the early postoperatory period of orthotopic heart transplantation

Meeting Abstract. 2018

Incidence and Prognosis of Colorectal Cancer After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumor Registry

Sagastagoitia-Fornie, Marta; (...); Crespo-Leiro, Maria G.

Article. 10.3389/ti.2023.11042. 2023

Infective endocarditis in patients with heart transplantation.

Martínez-Sellés M; (...); Muñoz P

Article. 10.1016/j.ijcard.2020.12.018. 2021

Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.

García-Cosío MD; (...); Delgado JF

Article. 10.3389/fcvm.2021.630113. 2021

Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.

Esteban-Fernández A; (...); Ridocci-Soriano F

Article. 10.1007/s00392-023-02241-0. 2024

Influence of the type of circulatory/ventricular assistance in the primary graft failure and heart transplantation mortality

Meeting Abstract. 2018

Influence on kinesiophobia by disability, physical, and behavioural variables after a heart transplantation.

Marques-Sule E; (...); Bäck M

Article. 10.1093/eurjcn/zvab134. 2022

Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center

Martin, PA; (...); Bonet, LA

Meeting Abstract. 2018

Is the Benefit of Treating Iron Deficiency Greater in Acute Heart Failure with Renal Dysfunction?

Lopez-Vilella, Raquel; (...); Almenar Bonet L

Article. 10.3390/life13040915. 2023

Is the benefit of treating iron deficiency greater in acute heart failure with renal dysfunction?

Lopez Vilella, R. Raquel; (...); Bonet, L. Almenar

Meeting Abstract. 2023

Is there a variation of CA-125 levels with changes in glomerular filtration rate in patients with heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Is there changes in the diuretic response to hypertonic saline plus furosemide depending on the type of heart failure?

Carrillo, D; (...); Almenar, L

Meeting Abstract. 2018

Kinesiophobia and associated variables in patients with heart failure.

Sentandreu-Mano, Trinidad; (...); Marques-Sule, Elena

Article. 10.1093/eurjcn/zvad072. 2023

Kinesiophobia in heart transplantation patients: a cross-sectional study with a special focus in sex differences

Moreno Segura, N.; (...); Marques-Sule, E.

Meeting Abstract. 2023

Kinesiophobia, physical activity and quality of life in patients with heart failure: a cross-sectional study

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Left ventricular myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis

Vives-Gilabert, Y; (...); Zorio, E

Article. 10.1016/j.ijcard.2018.09.024. 2019

Long term outcome of single ventricle physiology with pulmonary restriction not undergoing Fontan repair

Buendia, F; (...); Dos, L

Meeting Abstract. 2020

Long-term changes in left ventricular ejection fraction depending on the type of heart failure

Meeting Abstract. 2018

Long-term study of prevalence and evolution of tricuspid regurgitation after orthotopic heart transplantation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Massive Primary Mitral Regurgitation Due to Chordae Rupture: Treatment With New-Generation Edge-to-Edge Repair Devices.

Vilchez-Tschischke JP; (...); Diez-Gil JL

Editorial Material. 10.1016/j.jcin.2020.12.026. 2021

Mechanical circulatory support in severe primary graft dysfunction: Peripheral cannulation but not earlier implantation improves survival in heart transplantation.

Olivella, Aleix; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.healun.2023.03.008. 2023

Mechanism of Sinoatrial Node Dysfunction in a RyR(2)R420Q Mouse Model Ofcatecholaminergic Polymorphic Ventricular Tachycardia

Wang, YY; (...); Gomez, AM

Meeting Abstract. 10.1016/j.bpj.2016.11.2924. 2017

Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.

Ezzitouny, M.; (...); Martinez-Dolz, L.

Article. 10.1016/j.transproceed.2018.12.013. 2019

Mortality after the first hospital admission for acute heart failure de novo vs. acutely decompensated heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Mortality After the First Hospital Admission for Acute Heart Failure, De Novo Versus Acutely Decompensated Heart Failure With Reduced Ejection Fraction.

Article. 10.1016/j.amjcard.2023.03.008. 2023

Musculoskeletal disorders in men and women with heart transplantation. A cross-sectional study

Segura, N. Moreno; (...); Marques-Sule, E.

Meeting Abstract. 2023

Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker

Lopez-Sainz, A; (...); Garcia-Pavia, P

Letter. 10.1186/s13023-019-1140-3. 2019

No Obesity Paradox for Health-Related Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the VIDA Multicenter Study

Cassado-Valls, Paula; (...); Comin-Colet, Josep

Article. 10.3390/jcm13247558. 2024

Non-invasive diagnosis of cardiac rejection using small non-coding RNAs

Gimenez-Escamilla, I.; (...); Rosello-Lleti, E.

Meeting Abstract. 2022

Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON Trial.

Núñez J; (...); Bayés-Genís A

Article. 10.1161/JAHA.119.014254. 2020

Noninvasive Liver Assessment in Adult Patients With Fontan Circulation Using Acoustic Radiation Force Impulse Elastography and Hepatic Magnetic Resonance Imaging.

Buendia-Fuentes, F; (...); Martinez-Dolz, L

Article. 10.1177/2150135117732674. 2018

Novel Imaging Techniques for Heart Failure.

Melero-Ferrer JL; (...); Martinez-Dolz L

Article. 10.15420/cfr.2015:29:2. 2016

Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy

Esteban Fernandez, A. Alberto; (...); De Juan Baguda, J.

Meeting Abstract. 2024

Percutaneous biventricular mechanical assistance as a bridge to heart transplant.

Perez-Guillen, Manuel; (...); Martinez-Leon, Juan B

Case Reports. 10.1016/j.rec.2023.07.007. 2023

Peripheral access ultrafiltration as a treatment for cardiorenal syndrome with inadequate diuretic response. Initial experience

Letter. 10.1016/j.recesp.2022.04.017. 2023

Physical activity enjoyment, exercise motivation, and physical activity in patients with heart failure: A mediation analysis.

Klompstra L; (...); Marques-Sule E

Article. 10.1177/02692155221103696. 2022

Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.

Lozano-Edo S; (...); Martínez-Dolz L

Article. 10.1097/TP.0000000000003798. 2021

Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.

Romero S; (...); Sanz J

Article. 10.1080/10428194.2018.1474462. 2019

Practical Requirements for the Development of an Advanced Cardiorenal Unit

Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar

Review. 10.1159/000536104. 2024

Predicting Sarcopenia and Frailty Risk in Patients Post Heart Transplantation.

Sentandreu-Mano, Trinidad; (...); Machado, Felipe V C

Article. 10.1111/ctr.70027. 2025

Preliminary experience on the usefulness of immunoglobulin A as a biomarker in patients with decompensated heart failure

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2021

Presence and evolution of multiple pulmonary nodules with halo sign detected by computerized tomography in advanced heart failure

Meeting Abstract. 2018

Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study.

Article. 10.1016/j.transproceed.2022.09.009. 2022

Prevalence, characteristics, and phenotype associated with tachycardiomyopathy in a cohort of patients first hospitalized for heart failure with reduced ejection fraction

Otero Garcia, O.; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 2024

Prevalence, Characteristics, and Prognostic Relevance of Donor-Transmitted Coronary Artery Disease in Heart Transplant Recipients.

Couto-Mallón D; (...); Crespo-Leiro MG

Article. 10.1016/j.jacc.2023.06.016. 2023

Prevalence, Incidence, and Outcomes of Hyperkalaemia in Patients with Chronic Heart Failure and Reduced Ejection Fraction from a Spanish Multicentre Study: SPANIK-HF Design and Baseline Characteristics.

Delgado-Jimenez, Juan F.; (...); Crespo-Leiro, Maria G.

Article. 10.3390/jcm11051170. 2022

Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis.

Urbistondo, Francisco Gonzalez; (...); De Prada, Jose Antonio Vazquez

Article. 10.1016/j.rec.2023.10.006. 2023

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry

Vega, D. Garcia; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.1187. 2024

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry

Garcia Vega, D. David; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.1187. 2024

Prognostic implications of hypo and hyperkalaemia in acute heart failure with reduced ejection fraction. Analysis of cardiovascular mortality and hospital readmissions.

Laymito-Quispe RDP; (...); Almenar-Bonet, Luis

Article. 10.1016/j.medcli.2021.03.037. 2022

Real world comparison of spironolactone and eplerenone in patients with heart failure.

Pardo-Martinez, Patricia; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.ejim.2021.12.027. 2022

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIRE.

Ufnal, Marcin; (...); Rosenkranz, Stephan

Article. 10.1002/ehf2.15203. 2025

Repetitive ambulatory doses of levosimendan as a bridge to heart transplant: patients characteristics and prescription patterns from the LEVO-T Registry.

De Juan Baguda, J.; (...); Gonzalez Costello, J.

Meeting Abstract. 2022

Repetitive ambulatory doses of levosimendan for patients as bridge to heart transplant. Findings from the LEVO-T registry.

De Juan Baguda, J. Javier; (...); Gonzalez-Costello, J.

Meeting Abstract. 2022

Repetitive ambulatory levosimendan as a bridge to heart transplantation.

Baguda, Javier De Juan; (...); Gonzalez-Costello, Jose

Article. 10.1016/j.rec.2023.07.002. 2023

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.recesp.2021.06.010. 2022

Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry.

Salterain-Gonzalez, Nahikari; (...); Gonzalez-Vilchez, Francisco

Article. 10.1016/j.rec.2021.06.009. 2021

Revascularization of Donor Transmitted Coronary Artery Disease After Heart Transplantation: Impact on Survival and Cardiovascular Events. Insights from the DONOR-CAD Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023

Reversal of anticoagulation with idarucizumab. Initial experience in heart and heart-and-lung transplantation

Vilella, RL; (...); Bonet, LA

Meeting Abstract. 2018

Review of the allocation criteria for heart transplant in Spain in 2023 . SEC-Heart Failure Association/ONT/SECCE consensus document

González-Costello J; (...); Domínguez-Gil B

Review. 10.1016/j.rec.2023.11.001. 2024

Role of DNMT3B system in human ischemic hearts

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Role of vericiguat in management of patients with heart failure with reduced ejection fraction after worsening episode.

Olivella, Aleix; (...); Facila Rubio, Lorenzo

Article. 10.1002/ehf2.14647. 2023

Sarcomere ACTC1 and MYO18A serum expression levels detect acute cellular rejection in cardiac transplant patients

Perez Carrillo, L.; (...); Rosello-Lleti, E.

Meeting Abstract. 2021

Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry

Ambrosio, Giuseppe; (...); Maggioni, Aldo P.

Article. 10.1016/j.ejim.2021.04.001. 2021

Severity of Donor Transmitted Coronary Artery Disease and Survival after Heart Transplantation. Results from the Donor Coronary Artery Disease (DONOR-CAD) Study

Couto-Mallon, D.; (...); Crespo-Leiro, M. G.

Meeting Abstract. 2023

Sex differences in aortic prognosis in Marfan patients, a retrospective longitudinal study from the REPAG registry

Tura, G. Teixido; (...); Cabrera, F.

Meeting Abstract. 10.1093/eurheartj/ehae666.2264. 2024

Sex, Temporary Mechanical Circulatory Support, and HeartTransplantation: Insights From a Multi-Institutional SpanishRegistry.

Enriquez-Vazquez, Daniel; (...); Crespo-Leiro, Maria G.

Letter. 10.1016/j.jchf.2023.07.027. 2023

Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.

Del Canto I; (...); Núñez J

Article. 10.1161/JAHA.121.022214. 2022

Short-term changes in left and right ventricular CMR feature tracking strain following ferric carboxymaltose in patients with heart failure: a substudy of the Myocardial-IRON trial

Del Canto Serrano, I.; (...); Nunez, J. V.

Meeting Abstract. 2021

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Otero Garcia, O. Oscar; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. https://doi.org/10.1093/eurheartj/ehae666.836. 2024

Sinus rhythm restoration as an independent predictor of left ventricular ejection fraction improvement in patients with the first hospitalization for heart failure and reduced ejection fraction

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.836. 2024

Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis.

Article. 10.1016/j.ejim.2022.06.008. 2022

Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure

Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T

Article. 10.1016/j.recesp.2018.07.020. 2018

Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)

Gonzalez-Vilchez, F; (...); Abella-Anton, R

Article. 10.1016/j.rec.2019.09.005. 2019

Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vilchez F; (...); Groba Marco MDV

Article. 10.1016/j.rec.2020.06.035. 2020

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

Gonzalez-Vilchez, Francisco; (...); Jesus Valero-Masa, Maria

Article. 10.1016/j.recesp.2021.06.012. 2021

Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology.

Gonzalez-Vilchez, Francisco; (...); Valero-Masa, Maria Jesus

Article. 10.1016/j.rec.2021.08.001. 2021

Spanish heart transplant registry. 33rd official report of the Heart failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2022.06.011. 2022

Spanish heart transplant registry. 34th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2023.06.013. 2023

Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology.

González-Vílchez F; (...); García-Romero E

Article. 10.1016/j.rec.2024.05.015. 2024

Spanish multicenter study on the monitoring and incidence of hyperkalaemia in patients with heart failure and reduced ejection fraction. SPANIK-HF

Crespo-Leiro, M.; (...); Delgado-Jimenez, J. F.

Meeting Abstract. 2022

Specific test panels for patients with heart failure: implementation and use in the Spanish National Health System

Almenar Bonet, Luis; (...); Generosa Crespo-Leiro, Andmaria

Article. 10.1515/almed-2022-0006. 2022

Study design and rationale of the pAtients pResenTing with cOngenital heaRt dIseAse Register (ARTORIA-R)

Sinning, Christoph; (...); Kirchhof, Paulus

Article. 10.1002/ehf2.13574. 2021

Study of molecules involved in cellular traffic in advanced heart failure: are there differences in the nivels of these molecules between ischemic heart disease and idiopathic dilated cardiomyopathy?

Ezzitouny, M.; (...); Martinez-Dolz, L.

Meeting Abstract. 2018

Technology usage, interest and preferences about technology-based cardiac rehabilitation programmes in heart failure

Sempere-Rubio, N.; (...); Marques-Sule, E.

Meeting Abstract. 2022

Technology Usage, Physical Activity, and Motivation in Patients With Heart Failure and Heart Transplantation.

Deka P; (...); Marques-Sule E

Article. 10.1097/CIN.0000000000001049. 2023

Temporal trends in the use and outcomes of temporary mechanical circulatory support as a bridge to cardiac transplantation in Spain. Final report of the ASIS-TC study.

Barge-Caballero, Eduardo; (...); Crespo-Leiro, Maria G.

Article. 10.1016/j.healun.2022.10.020. 2022

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions.

Article. 10.3389/fcvm.2021.618398. 2021

Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2023

Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.

Article. 10.1002/ehf2.14386. 2023

Three cases of psychosis after use of sacubitril/valsartan.

Perez-Rosello, Victor; (...); Almenar-Bonet, Luis

Letter. 10.1016/j.recesp.2020.05.019. 2021

Time course and predictors for neoaortic root dilatation and neoaortic valve regurgitation during adult life after arterial switch operation.

Rueda Soriano, Joaquin; (...); Gallego, Pastora

Article. 10.1016/j.recesp.2020.01.031. 2020

Transient pulmonary nodules with halo sign in patients with advanced heart failure: a report of two cases.

López-Vilella R; (...); Bonet LA

Article. 10.1016/j.clinimag.2019.11.008. 2020

Ultrafiltracion de acceso periferico como tratamiento del sindrome cardiorrenal con insuficiente respuesta diuretica. Experiencia inicial.

Art Exhibit Review. 10.1016/j.rec.2022.04.013. 2022

Uncontrolled asistole donation. Impact on primary graft failure and heart transplantation survival

Donoso Trenado, V.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Unveiling the prognostic journey: renal function trajectories in 'de novo' heart failure with reduced ejection fraction - insights from a cohort study and their impact on patient outcomes

Garcia, O. Otero; (...); Gonzalez-Juanatey, J. R.

Meeting Abstract. 10.1093/eurheartj/ehae666.835. 2024

Use of a surgically implanted, extracorporeal continuous flow circulatory support system as a bridge to heart transplantation

Cabezon Villalba, G. Gonzalo; (...); Crespo-Leiro, M. G. C. L.

Meeting Abstract. 2023

Use of a surgically implanted, nondischargeable, extracorporeal continuous flow circulatory support system as a bridge to heart transplant.

Villalba, Gonzalo Cabezon; (...); Crespo-Leiro, Maria G

Article. 10.1016/j.rec.2023.05.002. 2024

Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain

Crespo-Leiro, MGMG; (...); Almenar-Bonet, L

Meeting Abstract. 2019

Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain.

Crespo-Leiro MG; (...); Almenar-Bonet L

Article. 10.1111/ctr.13748. 2019

Usefulness of biomarkers to predict prognosis after heart transplant

Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar

Article. 10.1016/j.rec.2024.04.019. 2024

Usefulness of Immunoglobulin A in Patients With Decompensated Heart Failure: Is It a Future Marker of Congestion? Preliminary Experience.

Article. 10.1016/j.transproceed.2021.07.051. 2021

Usefulness of short-term peripheral ambulatory ultrafiltration in heart failure refractory to diuretics. Initial experience.

Guerrero Cervera B; (...); Almenar Bonet L

Article. 10.1016/j.medcli.2023.04.008. 2023

Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation

Lopez-Vilella, RLV; (...); Bonet, LABA

Meeting Abstract. 2019

Utility of nucleocytoplasmic transport as a marker in critical heart failure with circulatory assistance as a bridge to transplant

Ezzitouny, M.; (...); Marinez-Dolz, L.

Meeting Abstract. 2020

Utility of the Biomarker CA125 in the Diagnosis of Cellular Rejection in Allogeneic Heart Transplantation.

Lopez-Vilella, R; (...); Bonet, LA

Article. 10.1016/j.transproceed.2021.07.058. 2021

Utility of the IMPACT score for predicting heart transplant mortality. Analysis on a contemporary cohort of the Spanish Heart Transplant Registry

Ortiz-Bautista, Carlos; (...); Delgado-Jimenez, Juan F.

Article. 10.1111/ctr.14774. 2022

Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination.

Pastor Pueyo, Pablo; (...); Worner Diz, Fernando

Article. 10.1007/s00392-023-02225-0. 2023

Validation of miR-181A-5p as a biomarker of acute rejection after heart transplantation. Multicenter study

Crespo-Leiro, M.; (...); Domenech-Garcia, N.

Meeting Abstract. 2023

Validation of the usefulness of 2-dimensional strain parameters to exclude acute rejection after heart transplantation: a multicenter study.

Goirigolzarri Artaza, Josebe; (...); Segovia Cubero, Javier

Article. 10.1016/j.recesp.2020.01.033. 2020

Value of SERCA2a as a Biomarker for the Identification of Patients with Heart Failure Requiring Circulatory Support.

Ezzitouny M; (...); Martínez-Dolz L

Article. 10.3390/jpm11111122. 2021

Value of the "Standing Test" in the Diagnosis and Evaluation of Beta-blocker Therapy Response in Long QT Syndrome.

Muñoz-Esparza C; (...); Gimeno Blanes JR

Article. 10.1016/j.rec.2017.01.006. 2017

Variation in diuretic requirement after peripheral ultrafiltration in heart failure with diuretic resistance

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Variations in the medical treatment of heart failure during admission for decompensation

Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2022

Well-Being, Physical Activity, and Social Support in Octogenarians with Heart Failure during COVID-19 Confinement: A Mixed-Methods Study

Marques-Sule, Elena; (...); Luis Cabanillas-Garcia, Juan

Article. 10.3390/ijerph192215316. 2022

What clinical parameters are associated with the prescription at hospital discharge of all medications with prognostic improvement? Analysis in de novo heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Bonet, Almenar

Meeting Abstract. 2024

What factors are associated with myocardial recovery following admission for acute heart failure? Study in patients with de novo diagnosis and reduced left ventricular ejection fraction

Donoso Trenado, V.; (...); Almenar-Bonet, L.

Meeting Abstract. 2024

What motivates heart transplantation patients to exercise and engage in physical activity? A network analysis.

Marques-Sule, Elena; (...); Machado, Felipe V C

Article. 10.1093/eurjcn/zvad051. 2023

Why Iron Deficiency in Acute Heart Failure Should Be Treated: A Real-World Clinical Practice Study.